Integramed America, Inc. (INMD) Reports In-Line Q3 EPS, Sales Increase 15% Y/Y
Integramed America, Inc. (NASDAQ: INMD) reported Q3 EPS of $0.12, in-line with the analyst estimate of $0.12. Revenue for the quarter came in at $69.4 million versus the consensus estimate of $68.51 million.